Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure

This publication has 33 references indexed in Scilit:

• Losartan in Heart Failure
  Circulation, 1995
• Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.
  Circulation, 1993
• Nonpeptide angiotensin II receptor antagonists. Studies with DuP 753 and EXP3174 in dogs
  European Journal of Pharmacology, 1991
• Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
  New England Journal of Medicine, 1991
• DuP 753 is a specific antagonist for the angiotensin receptor.
  Hypertension, 1991
• Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.
  Circulation, 1991
• Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure
  The American Journal of Cardiology, 1991
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987
• Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state.
  Heart, 1985
• Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in patients with heart failure
  Journal of the American College of Cardiology, 1985